Abstract:Objective To screen and identify serum protein biomarkers for the differential diagnosis between ischemic colitis (IC) and ulcerative colitis (UC) by tandem mass tag (TMT) combined with liquid chromatography/tandem mass spectrometry (LC-MS/MS).Methods From January 2018 to January 2019,at the First Affiliated Hospital of School of Medicine of Zhejiang University,patients with UC or IC,and health controls,each l0 cases,were enrolled into UC group,IC group and normal control (NC) group,respectively.Fasting serum samples of all the subjects were collected.After removal of high-abundance protein,followed by proteolysis,peptide labeling and fractionating,the samples were then processed by mass spectrometry.The protein with TMT data of three groups was obtained and protein with TMT value 0 were removed.Heat map of protein was constructed.The differential protein was defined as the protein fold change over 1.5 or less than 0.67.The Reactome database was used to cluster the pathways of differential proteins among groups.Statistical methods included t test,hypergeometry test and corrected by BH multiple test.Results A total of 357 serum proteins were identified by proteomic profiling.There were 27 differential proteins between the IC group and the NC group,including six up-regulated proteins and 21 down-regulated proteins.There were 228 differential proteins between the UC group and the NC group,including 75 up-regulated proteins and 153 down-regulated proteins.There were 49 differential proteins between UC group and IC group,including 22 up-regulated proteins and 27 down-regulated proteins.In the comparison of differential proteins between the NC group,IC group and UC group,only the expression of fibrin 3 was statistically significant (the fold change between UC and NC,between UC and IC,between IC and NC were 0.24,0.46 and 0.53,respectively;t =-5.089,-7.298 and -3.919,all P ＜ 0.01).The results of pathway cluster analysis showed that in the comparison of differential proteins between IC group and NC group,only the platelet degranulation pathway was enriched,and 10 proteins were involved in this pathway (P ＜ 0.01).In the comparison of differential proteins between UC group and NC group,there were 58 pathways enriched,of which 38 proteins were involved in the platelet degranulation pathway,16 proteins were involved in the initial complement trigger pathway,13 proteins were involved in the complement cascade pathway,and 11 proteins were involved in antibody-mediated complement activation pathway (all P ＜ 0.01).In the comparison of differential proteins between UC group and IC group,three different pathways were obtained.Among them,nine proteins were involved in the platelet degranulation pathway,seven proteins were involved in the initial complement trigger pathway,and five proteins were involved in the complement cascade pathway (all P ＜ 0.01).Conclusions The difference in serum proteome between IC patients and UC patients was significant,and the differential proteins are mainly involved in platelet activation and complement activation.The candidate proteins identified in this study may be used as biomarkers for the differential diagnosis of UC and IC in the future.

Proteomic Analysis of Colonic Mucosa by Two-Dimensional Gel Electrophoresis in Patients with Different Subtype Irritable Bowel Syndrome

Screening of Serological Markers for Differential Diagnosis Ischemic Colitis and Ulcerative Colitis by Proteomic Techniques

TMT proteomics analysis of intestinal tissue from patients of irritable bowel syndrome with diarrhea: Implications for multiple nutrient ingestion abnormality

Clinical Application and Identification of Proteomics in Colonic Mucosa of Sub-health People with Constipation*

Changes of Colonic 5-Hydroxytryptamine and 5-Hydroxytryptamine3 Receptor in Diarrhea-predominant Irritable Bowel Syndrome

Study on clinical significance of different subgroups of irritable bowel syndrome patients in Zhejiang province

The expression of protease-activated receptors in colon mucosa tissue of patients with diarrhea-predominant irritable bowel syndrome and its significance

Changes of colonic 5-hydoxytryptamine and 5-hydroxytryptamine, receptor in diarrhea-predominant irritable bowel syndrome

Phenotypic Analysis of Th Cells in Colon and Peripheral Blood in Patients with Irritable Bowel Syndrome

Pilot Study of Small Bowel Mucosal Gene Expression in Patients with Irritable Bowel Syndrome with Diarrhea.

Altered Intestinal Microbiota with Increased Abundance of Prevotella is Associated with High Risk of Diarrhea-Predominant Irritable Bowel Syndrome.

Analysis on Expression Imbalance of Peripheral Blood Inflammatory Cytokines in Patients with Irritable Bowel Syndrome

Comparative Proteomic Profiles of the Normal and Aganglionic Hindgut in Human Hirschsprung Disease.

Analysis of Differential Expressed Protein in the Intestinal Mucosa of Patient with Inflammatory Bowel Disease

Study of Colonic 5-HT3 Receptors in Diarrhea Prominent Irritable Bowel Syndrome

Differential Proteomics Analysis of Colonic Tissues in Patients of Slow Transit Constipation.

[Proteomics of the Colonic Mucosa in Sub-Healthy People with Shapeless Stool].

The Relationship Between Gut Microbiota and Proteolytic Activity in Irritable Bowel Syndrome.

Decreased Expression of Serotonin in the Jejunum and Increased Numbers of Mast Cells in the Terminal Ileum in Patients with Irritable Bowel Syndrome

IDENTIFICATION OF GUT MICROBIOTA AND METABOLITES SIGNATURE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME

Changes of Substance P, Vasoactive Intestinal Peptide and Mast Cell in Colonic Mucosa of Patients with Irritable Bowel Syndrome